drugset / Trial / NCT02062931

Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure

NCT02062931 ↗

NaSingle-groupOpen-labelTreatment

Summary

Stem cells (SC) are the foundation cells for every organ, tissue and cell in the body. They are undifferentiated "blank" cells that do not yet have a specific function. Under proper conditions, they begin to develop into specialized tissue and organs. They are self-sustaining and can replicate themselves for long periods of time. They have the remarkable potential to develop into many different cell types in the body. They serves as a sort of repair system for the body, they can theoretically divide without limit to replenish other cells as long as the person is still alive. Premature ovarian failure (POF) is the loss of ovarian function in women less than 40 years. It is associated with sex steroid deficiency, amenorrhea, infertility and elevated serum gonadotropins. POF occurs in 1 % of women. In majority of cases the underlying cause is not identified. Management essentially involves hormone replacement and infertility treatment. This work aimed to evaluate the therapeutic potential of Autologous MSC transplantation in women suffering from Premature Ovarian Failure.

Timeline

Start
2012-03
Primary completion
2015-05
Completion
2016-11

Publications

  • Results M. Edessy, Hala N. Hosni, Y. Wafa, S Bakry, Y.Shady and M.Kamel. Stem Cells Transplantation in Premature Ovarian Failure.World Journal of Medical Sciences 10 (1): 12-16, 2014

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous mesenchymal stem cells Cell therapy 3e+06 cells Other
Subject Autologous mesenchymal stem cells Cell therapy 5e+06 cells Other